In the current study, 25 Egyptian patients clinically diagnosed with pulmonary arterial hypertension (PAH) and 10 healthy candidates have been screened for pathogenic variants in BMPR2 genes using direct Sanger sequencing. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.